Cargando…
Epigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer
Resistance to cytotoxic chemotherapy is a major cause of mortality in colorectal cancer (CRC) patients. A small subset of cancer cells, termed “cancer stem cells” (CSCs), are believed to be key contributors of chemoresistance and tumor recurrence. Recently, epigallocatechin-3-gallate (EGCG), an acti...
Autores principales: | Toden, Shusuke, Tran, Hanh-My, Tovar-Camargo, Oscar A., Okugawa, Yoshinaga, Goel, Ajay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941304/ https://www.ncbi.nlm.nih.gov/pubmed/26930714 http://dx.doi.org/10.18632/oncotarget.7567 |
Ejemplares similares
-
Oligomeric proanthocyanidins (OPCs) target cancer stem-like cells and suppress tumor organoid formation in colorectal cancer
por: Toden, Shusuke, et al.
Publicado: (2018) -
Epigallocatechin gallate inhibits dimethylhydrazine-induced colorectal cancer in rats
por: Wang, Yu, et al.
Publicado: (2020) -
TIAM1 promotes chemoresistance and tumor invasiveness in colorectal cancer
por: Izumi, Daisuke, et al.
Publicado: (2019) -
Epigallocatechin Gallate Nanodelivery Systems for Cancer Therapy
por: Granja, Andreia, et al.
Publicado: (2016) -
Epigallocatechin gallate inhibits the proliferation of colorectal cancer cells by regulating Notch signaling
por: Jin, Heiying, et al.
Publicado: (2013)